Why Apogee Therapeutics Stock Triumphed on Thursday

The company aims to raise gross proceeds of roughly $300 million in a new capital-raising effort.Apogee Therapeutics (APGE 12.64%) stock was the cure for many an ailing stock portfolio on the second-to-last trading day of the week. The company's shares got a boost from some encouraging news on the financing front, and they closed the day nearly 13% higher in value. It's an understatement to say this compared favorably to the S&P 500's (^GSPC -0.28%) 0.3% decline.New stock on the wayApogee, a clinical-stage ...